Clinical and Laboratory Investigation
Treatment of Pediatric Pyogenic Granulomas Using β-Adrenergic Receptor Antagonists
Version of Record online: 21 OCT 2013
© 2013 Wiley Periodicals, Inc.
Volume 31, Issue 2, pages 203–207, March/April 2014
How to Cite
Wine Lee, L., Goff, K. L., Lam, J. M., Low, D. W., Yan, A. C. and Castelo-Soccio, L. (2014), Treatment of Pediatric Pyogenic Granulomas Using β-Adrenergic Receptor Antagonists. Pediatric Dermatology, 31: 203–207. doi: 10.1111/pde.12217
- Issue online: 9 MAR 2014
- Version of Record online: 21 OCT 2013
Propranolol and timolol are nonselective ß-adrenergic antagonists that induce peripheral vasoconstriction and affect angiogenic cytokines. Oral and topical ß-blocker therapy has become the de facto first-line treatment for complicated infantile hemangiomas because of its superior efficacy and tolerability. Pyogenic granulomas or lobular capillary hemangiomas are common acquired vascular tumors accounting for 0.5% of all skin nodules in children. Although they are benign vascular proliferations, treatment is often sought because of recurrent episodes of bleeding and for cosmetic considerations. Numerous treatment options are available, but recurrence rates are high. Noninvasive methods of treatment are being sought, particularly for young children. Herein we report a series of seven cases of cutaneous and mucosal pyogenic granulomas treated successfully using oral or topical ß-blockers.